EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?

Martyna Cieślik, Krzysztof Bryniarski, Katarzyna Nazimek

Frontiers in Cell and Developmental Biology · 05.07.2023 · 11

DOI: 10.3389/fcell.2023.1211833 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 05.07.2023. Verfasst von Martyna Cieślik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstwo Edukacji i Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

At present, extracellular vesicles (EVs) are considered key candidates for cell-free therapies, including treatment of allergic and autoimmune diseases. However, their therapeutic effectiveness, dependent on proper targeting to the desired cells, is significantly limited due to the reduced bioavailability resulting from their rapid clearance by the cells of the mononuclear phagocyte system (MPS). Thus, developing strategies to avoid EV elimination is essential when applying them in clinical practice. On the other hand, malfunctioning MPS contributes to various immune-related pathologies. Therapeutic reversal of these effects with EVs would be beneficial and could be achieved, for example, by modulating the macrophage phenotype or regulating antigen presentation by dendritic cells. Additionally, intended targeting of EVs to MPS macrophages for replication and repackaging of their molecules into new vesicle subtype can allow for their specific targeting to appropriate populations of acceptor cells. Herein, we briefly discuss the under-explored aspects of the MPS-EV interactions that undoubtedly require further research in order to accelerate the therapeutic use of EVs.

Schlagwörter

Stichwörter der Autor:innen

cell-free therapeuticsdendritic cellsexosomesextracellular vesiclesimmunotherapymacrophagesmonocytesmononuclear phagocyte system

Autor:innen und Institutionen

  • Department of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland.

Förderung

  • Ministerstwo Edukacji i Nauki

Zitieren

APA

Cieślik, M., Bryniarski, K., & Nazimek, K. (2023). Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1211833

Vancouver

Cieślik M, Bryniarski K, Nazimek K. Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1211833

BibTeX
@article{Cielik2023,
  author = {Cieślik, Martyna and Bryniarski, Krzysztof and Nazimek, Katarzyna},
  title = {Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fcell.2023.1211833}
}
Kostenlos starten →